SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-074133
Filing Date
2024-06-24
Accepted
2024-06-24 07:30:34
Documents
13
Period of Report
2024-06-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417734d2_8k.htm   iXBRL 8-K 28179
  Complete submission text file 0001104659-24-074133.txt   202837

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alim-20240619.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alim-20240619_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alim-20240619_pre.xml EX-101.PRE 22373
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2417734d2_8k_htm.xml XML 3685
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 241062104
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)